HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Foster, D. B. Articles by Mak, A. S. Search for Related Content PubMed PubMed Citation Articles by Foster, D. B. Articles by Mak, A. S. Social Bookmarking                      What's this?

J Biol Chem, Vol. 275, Issue 3, 1959-1965, January 21, 2000

Phosphorylation of Caldesmon by p21-activated Kinase
IMPLICATIONS FOR THE Ca²⁺ SENSITIVITY OF SMOOTH MUSCLE CONTRACTION^*

D. Brian Foster^§, Li-Hua Shen, John Kelly^¶, Pierre Thibault^¶, Jennifer E. Van Eyk^**, and Alan S. Mak

From the Departments of  Biochemistry and  Physiology, Queen's University, Kingston Ontario, Canada K7L 3N6 and the ^¶ National Research Council of Canada, Ottawa, Ontario, Canada K1A 0R6

	ABSTRACT

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

We have previously shown that p21-activated kinase, PAK, induces Ca²⁺-independent contraction of Triton-skinned smooth muscle with concomitant increase in phosphorylation of caldesmon and desmin but not myosin-regulatory light chain (Van Eyk, J. E., Arrell, D. K., Foster, D. B., Strauss, J. D., Heinonen, T. Y., Furmaniak-Kazmierczak, E., Cote, G. P., and Mak, A. S. (1998) J. Biol. Chem. 273, 23433-23439). In this study, we provide biochemical evidence implicating a role for PAK in Ca²⁺-independent contraction of smooth muscle via phosphorylation of caldesmon. Mass spectroscopy data show that stoichiometric phosphorylation occurs at Ser⁶⁵⁷ and Ser⁶⁸⁷ abutting the calmodulin-binding sites A and B of chicken gizzard caldesmon, respectively. Phosphorylation of Ser⁶⁵⁷ and Ser⁶⁸⁷ has an important functional impact on caldesmon. PAK-phosphorylation reduces binding of caldesmon to calmodulin by about 10-fold whereas binding of calmodulin to caldesmon partially inhibits PAK phosphorylation. Phosphorylated caldesmon displays a modest reduction in affinity for actin-tropomyosin but is significantly less effective in inhibiting actin-activated S1 ATPase activity in the presence of tropomyosin. We conclude that PAK-phosphorylation of caldesmon at the calmodulin-binding sites modulates caldesmon inhibition of actin-myosin ATPase activity and may, in concert with the actions of Rho-kinase, contribute to the regulation of Ca²⁺ sensitivity of smooth muscle contraction.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Recent data strongly implicate the monomeric Rho family GTPases in modulating Ca²⁺ sensitivity of smooth muscle contraction (1, 2). RhoA-activated kinase, Rho kinase, enhances the Ca²⁺ sensitivity of contraction by phosphorylating the myosin-binding subunit of SMPP1¹ resulting in inhibition of its activity (3) and/or by phosphorylating Ser¹⁹ of MLC directly (4). Rac1 and cdc42 have been implicated in the cytoskeletal remodeling processes that accompany lamellapodia and filopodia formation in many types of non-muscle cells (6). One of the key downstream effectors of Rac1 and cdc42 is the Ser/Thr kinase, PAK (7). We have shown previously that infusion of Triton-skinned guinea pig Taenia coli smooth muscle fibers with constitutively active PAK3 induces Ca²⁺-independent contraction to about 60% of the force obtained in the presence of Ca²⁺/calmodulin (8). PAK-induced contraction is accompanied by an increase in the phosphorylation of caldesmon and desmin but not MLC even though PAK is able to phosphorylate MLC at Ser¹⁹ in vitro (8, 9). These results suggest that Rac and cdc42, in contrast to Rho, induce smooth muscle contraction by altering the properties of actin and/or intermediate filaments.

Smooth muscle caldesmon is speculated to be a thin filament regulatory protein by virtue of its ability to inhibit actin-tropomyosin activated ATPase activity of myosin (10-12). It is an 89-kDa protein that binds in an extended conformation along filaments of actin-tropomyosin. It houses binding sites for myosin (13), tropomyosin (14), calmodulin (15, 41), and actin (16). In vitro, caldesmon-mediated inhibition of actomyosin ATPase activity can be regulated by calcium binding proteins, including calmodulin (17, 18) or caltropin (19).

Our finding that PAK induces Ca²⁺-independent contraction in skinned smooth muscle fibers (8) and the recent demonstration that an unknown kinase besides MAPK phosphorylates gizzard caldesmon in vivo (20) suggest that PAK phosphorylation of caldesmon may be involved in the regulation of Ca²⁺ sensitivity of smooth muscle contraction. Here, we report biochemical evidence supporting a role of PAK in the Ca²⁺ sensitivity of smooth muscle contraction via phosphorylation of caldesmon. Specifically, we have identified the sites of phosphorylation and have studied phosphorylated caldesmon with respect to its affinity for actin-tropomyosin and calmodulin and its ability to inhibit actomyosin ATPase activity.

	MATERIALS AND METHODS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Protein Preparation-- h-Caldesmon and   tropomyosin were purified from chicken gizzards essentially as described by Bretscher (21). Skeletal muscle actin was purified from rabbit muscle as outlined in (22). Smooth muscle myosin S1 was prepared by papain cleavage of gizzard myosin (23). Rabbit skeletal myosin S1(A1) was prepared by cleavage with chymotrypsin as described in (24). Recombinant murine PAK3, was expressed from the plasmid pGST-mPAK3 in Escherichia coli JM101 and/or JM110 cells as described before (8).

Phosphorylation of Caldesmon and Identification of Phosphorylation Sites-- Caldesmon (1-2 mg/ml) was phosphorylated by GST-mPAK3 (~5 µg/ml), at 37 °C for 60 min, in 20 mM Tris, pH 7.5, 100 mM NaCl, 5 mM MgCl₂, 1 mM [-³²P]ATP (1-5 × 10⁵ cpm/nmol), 0.5 mM DTT. Quantification of phosphorylation and analysis of phosphorylated amino acids were performed as described before (25).

Approximately 200 µg of caldesmon was dissolved in 200 µl of 100 mM NH₄HCO₃, pH 7.9, containing 10 µg of endoproteinase Glu-C. The digestion was carried out overnight at room temperature. The digest solutions were evaporated to dryness and redissolved in 5% acetic acid (200 µl). For nanoelectrospray mass spectrometry analysis, 20-µl aliquots of the sample solutions were desalted using ZipTip^TM C₁₈ (Millipore, Bedford, MA). Approximately 1-2 µl of the desalted solutions were used for both precursor ion scanning and tandem mass spectrometry (MS/MS) analyses.

Phosphopeptides were detected by precursor ion scanning (precursors of m/z 79) in negative ion mode on a API 3000 triple quadrupole mass spectrometer (Perkin Elmer/SCIEX Concord, ON, Canada). Precursor ion spectra were acquired in multiple channel acquisition mode, typically over a period of 3 min (m/z 400-2000, 0.5 mass units step size, 5 msec dwell time). Argon was used as the collision gas, and the collision offset voltage was 80 V. Phosphopeptide sequencing was achieved by MS/MS using a prototype quadruple time-of-flight mass spectrometer (QqTOFMS, Perkin Elmer/SCIEX) equipped with a nanoelectrospray ionization source. Product ion spectra were carried out in positive ion mode using argon as the collision gas and a collision energy of 60 eV (laboratory frame of reference). MS/MS spectra were typically acquired every 2 s over a period of 3 min.

Calmodulin-Caldesmon Interaction-- Interaction between calmodulin and phosphorylated and nonphosphorylated caldesmon was studied using intrinsic Trp fluorescence as described previously (15). The binding buffer was 20 mM Tris-HCl, pH 7.2, 0.5 mM CaCl₂, 100 mM NaCl, 1 mM DTT. The excitation wavelength was 295 nm with a slit width of 10 nm. Intensity measurement was made with a 290-nm filter at 330 nm and a slit width of 10 nm. Binding curves were fitted to a binding equation to obtain dissociation constants as described before (15) except that binding stoichiometry was set to 1 mol of caldesmon per mol of calmodulin as previously determined (15).

Actin-binding Assays-- Two nmol of actin was mixed with 0.4 nmol of tropomyosin and 0 to 1.5 nmol of phosphorylated or nonphosphorylated caldesmon in 200 µl of binding buffer (40 mM Tris, pH 7.5, 100 mM NaCl, 5 mM MgCl₂, and 1 mM DTT). Protein mixtures were allowed to equilibrate for 30 min prior to centrifugation at 100,000 × g in a Beckman TL-100 ultracentrifuge. Pellets were rinsed with actin-binding buffer once and dissolved in 100 µl of 0.05% (v/v) TFA in water. Relative amounts of caldesmon, tropomyosin, and actin were determined by high performance liquid chromatography using a Zorbax SB300-C8 HPLC column (5).

Actin-activated S1-ATPase Assays-- Actin-activated myosin S1 ATPase assays in the presence and absence of tropomyosin were conducted in a 96-well ELISA plate (100 µl assay volume). Inorganic phosphate was determined colorimetrically as described in (38). ATPase buffer contained 40 mM Tris, pH 7.5, 50 mM NaCl, 5 mM MgCl_2, and 1 mM DTT. Myosin S1 ATPase activity was determined for reaction mixtures containing 0-4 µM caldesmon, 10 µM actin, and 0.5 µM S1 with or without 2 µM tropomyosin for 10 min at 37 °C. ATPase reaction was initiated with 4 mM ATP and terminated by adding 100 µl of a solution containing 3% ascorbic acid, 0.5 M HCl, 4% SDS, and 0.5% (w/v) ammonium molybdate. Color was allowed to develop for 6 min prior to the addition of 2% sodium citrate and 2% sodium m-arsenite followed by 10-min incubation before absorbance at 650 nm was measured in a Molecular Dynamics E-max plate reader. Phosphate content was determined by comparison to a potassium phosphate standard curve. Less than 10% of the ATP was hydrolyzed over the course of the reaction. Phosphate release was linear within the 10-min reaction.

	RESULTS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Chicken gizzard h-caldesmon was phosphorylated in vitro using a constitutively active murine GST-PAK3 to a maximum of 2 mol of phosphate per mol of caldesmon as shown in Fig. 1. Only phosphorylated Ser was recovered from a hydrolysate of ³²P-labeled caledesmon (Fig. 1, inset).

View larger version (15K): [in this window] [in a new window]   Fig. 1.   Phosphorylation of caldesmon by mPAK3 in the presence and absence of calmodulin. Caldesmon (1 mg/ml) was phosphorylated by recombinant constitutively active GST-mPAK3 in the presence () or absence () of Ca2+/calmodulin (0.4 mg/ml) as outlined under "Materials and Methods." Inset, autoradiogram of 32P-labeled amino acid recovered from partial acid hydrolysis of phosphorylated caldesmon; Pi, inorganic phosphate; P-Ser, phosphorylated Ser; O, origin.

To locate the phosphorylation sites, caldesmon phosphorylated by GST-PAK to 2 mol of phosphate/mol of protein was subjected to digestion by endoproteinase Glu-C, which cleaves peptide bonds on the COOH-side of Glu residues. The resulting digest was analyzed for phosphorylated peptides by precursor ion scanning as described in "Materials and Methods." Two major doubly deprotonated ions were detected (Fig. 2A, peaks a and b) together with a number of minor peaks representing minor sites of phosphorylation. MS/MS sequence analysis determined that peak a (m/z 648.0) and peak b (m/z 754.0) correspond to two singly phosphorylated peptides, Gly⁶⁵¹-Val-Arg-Asn-Ile-Lys-p-Ser-Met-Trp-Glu⁶⁶⁰ and Thr⁶⁷⁸-Ala-Gly-Leu-Lys-Val-Gly-Val-Ser-p-Ser-Arg-Ile-Asn-Lys-Glu⁶⁹¹, A and B, respectively (data not shown). Ser⁶⁵⁷, being the only Ser in peptide A, can be unambiguously assigned as the site of phosphorylation in this peptide. There are two adjacent Ser residues in peptide B however. MS/MS sequence analysis indicated that Ser⁶⁸⁷ is most likely the site of phosphorylation (Fig. 2C) because a b-type fragment ion at m/z 813.5 corresponding to the unphosphorylated peptide, Thr-Ala-Gly-Leu-Lys-Val-Gly-Val-Ser⁶⁸⁶_, was detected (data not shown). The nonphosphorylated counterparts of peptides A and B were not detected, indicating that Ser⁶⁵⁷ and Ser⁶⁸⁷ were fully phosphorylated, largely accounting for the observed stoichiometry of 2 mol of phosphate/mol of protein (Fig. 1). The precursor ion scan of the endoproteinase Glu-C digest of unphosphorylated caldesmon shows no trace of peak a (m/z 648.0) or peak b (m/z 754.0), indicating that Ser⁶⁵⁷ and Ser⁶⁸⁷ are genuine PAK-target sites (Fig. 2B). Background peaks at m/z 529, 543, and 558, which amount to less than 12% of peak b, were detected in the unphosphorylated caldesmon sample but were not analyzed further.

View larger version (19K): [in this window] [in a new window]   Fig. 2.   Identification of phosphorylation sites in caldesmon incubated with mPAK3. A, precursor ion scan of m/z 79 (-ve ion mode) of the endoproteinase Glu-C digest of phosphorylated chicken gizzard caldesmon. Peaks a (m/z = 648.0) and b (m/z = 754.0) represent the two major doubly-deprotonated ions. Sequence analyses by tandem mass spectrometry determined the sequences of peaks a and b to be Gly651-Val-Arg-Asn-Ile-Lys-p-Ser-Met-Trp-Glu660 and Thr678-Ala-Gly-Leu-Lys-Val-Gly-Val-Ser-p-Ser-Arg-Ile-Asn-Lys-Glu691, respectively. B, precursor ion scan of m/z 79 of the endoproteinase Glu-C digest of unphosphorylated caldesmon. C, the functional domains in subdomain 4 of caldesmon; the calmodulin-binding sites A and B are boxed, and the phosphorylation sites by PAK at Ser657 and Ser687 are indicated.

According to the model of Marston and Redwood (Ref. 26, and Fig. 2C), Ser⁶⁵⁷ and Ser⁶⁸⁷ are located at the amino-terminal ends of calmodulin-binding sites A and B (15, 16) in subdomain 4. We therefore examined whether Ser⁶⁵⁷ and Ser⁶⁸⁷ were accessible to PAK when caldesmon formed a complex with Ca²⁺/calmodulin. GST-PAK3-phosphorylated caldesmon-calmodulin complex at a similar initial rate but reach a stoichiometry of 1.2 mol of phosphate/mol of protein (Fig. 1). Calmodulin was not phosphorylated by PAK, and Ca²⁺ did not affect PAK activity under the same conditions (data not shown). This result suggests that binding of calmodulin to sites A and B of caldesmon renders Ser⁶⁵⁷ and/or Ser⁶⁸⁷ less accessible to PAK.

To determine whether introduction of phosphate groups to Ser⁶⁵⁷ and Ser⁶⁸⁷ at the calmodulin-binding sites A and B can affect calmodulin-binding, we compared binding of phosphorylated and nonphosphorylated caldesmon to calmodulin using intrinsic Trp fluorescence measurements (Fig. 3). Phosphorylated and nonphosphorylated caldesmon have similar fluorescence spectra, each exhibiting a similar emission maximum at 350 nm, which suggests that the phosphate groups do not cause significant changes in the environments surrounding the Trp residues which are major determinants for calmodulin-binding (15). Binding of Ca²⁺-calmodulin, which contains no Trp, increased the intrinsic Trp fluorescence of caldesmon by a maximum of about 70% (Fig. 3B) and caused a blue shift of the emission maximum from 350 to 340 nm (Fig. 3A). On the other hand, calmodulin increases the fluorescence intensity by less than 40% at saturation accompanied by a smaller shift in emission maximum from 350 to 345 nm (Fig. 3B). As shown in Fig. 3B, phosphorylation reduces the affinity of caldesmon for Ca²⁺-calmodulin by about 10-fold and increases the K_d from 0.1 to 0.9 µM.

View larger version (18K): [in this window] [in a new window]   Fig. 3.   Effect of phosphorylation on binding of caldesmon to calmodulin. A, Trp fluorescence emission spectra of phosphorylated caldesmon with calmodulin (- - -) and unphosphorylated caldesmon with calmodulin (). In the absence of calmodulin, the emission spectra of phosphorylated and nonphosphorylated caldesmon are virtually identical as indicated by the solid triangles (). Excitation was at 295 nm. B, binding curves of phosphorylated () and nonphosphorylated () caldesmon to calmodulin using intrinsic Trp fluorescence measurements. I is the change in fluorescence in caldesmon at 330 nm induced by calmodulin; Io is fluorescence of caldesmon in the absence of calmodulin.  = wavelength. Inset, 12% SDS-polyacrylamide gel electrophoresis of the phosphorylated and unphosphorylated caldesmon and calmodulin at the end of the binding studies.

We compared the ability of caldesmon and its phosphorylated counterpart to interact with actin-tropomyosin and to inhibit actin-activated myosin ATPase activity because the calmodulin-binding site A has been shown to bind actin (27), and site B is in the middle of the tropomyosin-linked actin-binding and inhibitory region in subdomain 4 (28). As shown in Fig. 4, caldesmon phosphorylated to 2 mol of phosphate/mol of protein has a modest reduction in affinity for actin-tropomyosin; K_d was increased by less than 2-fold from 1.0 to 1.7 µM. However, phosphorylation of caldesmon induces a significant release of inhibition of actin-S1 ATPase (Fig. 5) in the presence or absence of tropomyosin. At 0.2 mol/mol of caldesmon/actin, nonphosphorylated caldesmon inhibits actin-activated skeletal myosin S1 ATPase activity by 80% in the presence of tropomyosin, whereas about 40% inhibition was observed by the same amount of phosphorylated caldesmon (Fig. 5B). Similar results were obtained using smooth muscle S1 (data not shown). In the absence of tropomyosin (Fig. 5A), caldesmon is much less effective in inhibition as reported by others (28, 29); 0.4-0.5 mol/mol of nonphosphorylated caldesmon/actin is required to cause a 40% inhibition whereas similar amounts of phosphorylated caldesmon inhibit by 20%.

View larger version (16K): [in this window] [in a new window]   Fig. 4.   Effect of phosphorylation on binding of caldesmon to actin-tropomyosin. Binding curves of unphosphorylated caldesmon () and phosphorylated caldesmon () to actin-tropomyosin was analyzed by sedimentation.

View larger version (22K): [in this window] [in a new window]   Fig. 5.   Inhibition of actin-activated skeletal S1-ATPase activity by caldesmon and phosphorylated caldesmon. A, inhibition of actin-activated S1-ATPase activity by unphosphorylated () and phosphorylated caldesmon () in the absence of tropomyosin. B, same as panel A except that tropomyosin was present.

	DISCUSSION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

This study provides biochemical evidence to support the hypothesis that phosphorylation of caldesmon by PAK may play a role in inducing Ca²⁺-independent contraction in smooth muscle. The strategic location of Ser⁶⁵⁷ and Ser⁶⁸⁷ in the calmodulin-binding sites A and B provides a crucial clue to our understanding of how phosphorylation of these sites may affect the function of caldesmon. The sequences around Ser⁶⁵⁷ and Ser⁶⁸⁷ are conserved in chicken, mouse, and human caldesmon, and these regions also form parts of the extended actin-binding regions in subdomain 4 (28), further underscoring their importance. Ser⁶⁵⁷ and Ser⁶⁸⁷ are not recognized by MAPK (25, 30), casein kinase II (31), Ca²⁺-dependent calmodulin kinase II (32), and protein kinase C (33), all of which have been shown to phosphorylate caldesmon in vitro. The sequences surrounding Ser⁶⁵⁷ (Arg-Asn-Ile-Lys-Ser⁶⁵⁷-Met-Trp-Glu) and Ser⁶⁸⁷ (Lys-Val-Gly-Val-Ser-Ser⁶⁸⁷-Arg-Ile-Asn) in caldesmon, and Ser¹⁹ (Gln-Arg-Ala-Thr-Ser¹⁹-Asn-Val-Phe) in MLC have a hydrophobic residue in the +2 position which agrees with Brzeska et al. (39) who showed that a Tyr at the +2 position is strongly preferred by PAK1. As well, seven of the eight autophosphorylation sites in PAK1 have a hydrophobic residue in position +2 (40). However, Tuazon et al. (34), using a series of synthetic peptide substrates, identified the signature determinants for PAK1 phosphorylation as KRES, which bears little resemblance to the caldesmon and MLC phosphorylation sites except for the presence of a basic residue between positions 1 and 5. It appears, therefore, secondary structures and a hydrophobic amino acid at the +2 position are equally important determinants for PAK recognition.

Not unexpected, we found that phosphorylation of Ser⁶⁵⁷ and Ser⁶⁸⁷ interfered with interaction between calmodulin and caldesmon. We have shown previously that although Trp⁶⁵⁹ and Trp⁶⁹² in sites A and B, respectively, are major determinants for caldesmon-calmodulin interaction, though amino acid residues surrounding the Trp residues also contribute to optimal binding (15). NMR data showed that sites A and B in synthetic peptides simultaneously bind to the two hydrophobic regions of calmodulin affecting all eight Met residues in the "Met puddles" (35) and become -helical upon binding to calmodulin (36, 37). Furthermore, the helix formed by site A is amphiphilic such that Ser⁶⁵⁷ is located on the polar surface (36). Introduction of phosphate groups at these sites likely interferes with the contacts between the polar surface of site A and calmodulin but should have a minor impact on hydrophobic interactions, as would be suggested by fluorescence data (Fig. 3A), which indicate that phosphorylation of caldesmon alone does not affect the environment surrounding Trp residues in sites A and B. This is also consistent with our finding that binding of calmodulin to sites A and B attenuates subsequent phosphorylation of caldesmon by PAK, indicating that Ser⁶⁵⁷ and/or Ser⁶⁸⁷ become less accessible to PAK (Fig. 1).

The actin-binding sites span an extended region in subdomain 4 of caldesmon (28). Introduction of two phosphates at Ser⁶⁵⁷ and Ser⁶⁸⁷ is unlikely to induce extensive disruption in the actin-binding regions, thus abrogating interaction. This may account for the modest reduction in affinity of phosphorylated caldesmon for actin-tropomyosin (Fig. 4), which might perhaps be because of a reorientation of the caldesmon molecule along the actin-tropomyosin filament toward forming a noninhibitory state. This interpretation is consistent with our finding that phosphorylation significantly reduces the ability of caldesmon to inhibit myosin S1-ATPase. A synthetic peptide spanning from Gly⁶⁵¹ to Ser⁶⁶⁷ containing site A has been shown to bind actin and enhance contraction in saponin-treated single hyper-permeable ferret aorta smooth muscle cells (27). Ser⁶⁸⁷ and site B are situated in the midst of a tropomyosin-dependent actin-binding region, residues 669-710, which is believed to be involved in tropomyosin-linked caldesmon inhibition of actomyosin ATPase activity (28). It is conceivable that phosphorylation of Ser⁶⁸⁷ and Ser⁶⁵⁷ is responsible for altering the tropomyosin-dependent and tropomyosin-independent inhibition, respectively.

As shown in Fig. 5B, PAK-phosphorylation attenuates (~50%), but does not abolish, caldesmon inhibition of actin-TM-activated myosin S1 ATPase activity invoking a phosphorylation mechanism by which caldesmon function can be modulated independently of Ca²⁺/calmodulin. It appears that caldesmon can exist in a number of states endowed with different inhibitory activities depending on its phosphorylation status and binding to Ca²⁺/calmodulin. One of these states, which is generated by Ca²⁺-independent phosphorylation of Ser⁶⁵⁷ and Ser⁶⁸⁷ with PAK, possesses intermediate inhibitory activity compared with the fully inhibitory nonphosphorylated caldesmon and the noninhibitory Ca²⁺/calmodulin-caldesmon complex. It is possible that introduction of phosphate groups to the calmodulin-binding region may engender a simulacrum of the Ca²⁺-calmodulin-bound state of caldesmon, thus accounting for the partial reversion of inhibition. Formation of a complex between phosphorylated caldesmon and calmodulin, however, appears unfavorable in view of results showing that the affinity of phosphorylated caldesmon for Ca²⁺/calmodulin is reduced 10-fold and that Ser⁶⁵⁷ and/or Ser⁶⁸⁷ in the caldesmon-calmodulin complex are less accessible to PAK (Fig. 3). Taken together, data from this study and others suggest that Rac1cdc42 and Rho GTPase may act in concert to target thin- and thick-filament, respectively, modulating Ca²⁺ sensitivity of smooth muscle contraction.

	ACKNOWLEDGEMENTS

We thank S. Bagrodia and R. A. Cerione for the gifts of GST-mPAK3. We extend thanks to Nina Buscemi and Lenny Organ for technical assistance and to Dr. Irena Neverova for helpful suggestions.

	FOOTNOTES

^* This work was funded by the Medical Research Council of Canada Grants MT-14303 (to A. S. M.) and MT-14375 (to J. V. E.) and Ontario Heart and Stroke Foundation Grants T-3458 (to A. S. M.) and T-3759 (to J. V. E.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

^§ Ontario Graduate Scholar.

^** Heart and Stroke Foundation National Scholar. To whom correspondence should be addressed: Dept. of Physiology, 4th Floor, Botterell Hall, Queen's University, Kingston, Ontario, Canada, K7L 3N6. Tel.: 613-533-6535; Fax: 613-533-6880; Email: jve1@post.queensu.ca.

	ABBREVIATIONS

The abbreviations used are: SMPP1, smooth muscle myosin light chain phosphatase; MLCK, myosin light chain kinase; PAK, p21-activated kinase; MLC, 20-kDa regulatory myosin light chain; MAPK, mitogen-activated protein kinase; DTT, dithiothreitol; MS/MS, tandem mass spectrometry; GST, glutathione S-transferase.

	REFERENCES

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				W. T. Gerthoffer Migration of Airway Smooth Muscle Cells Proceedings of the ATS, January 1, 2008; 5(1): 97 - 105. [Abstract] [Full Text] [PDF]

				R. J. Sandoval, E. R. Injeti, W. T. Gerthoffer, and W. J. Pearce Postnatal maturation modulates relationships among cytosolic Ca2+, myosin light chain phosphorylation, and contractile tone in ovine cerebral arteries Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2183 - H2192. [Abstract] [Full Text] [PDF]

				K. A. Sheehan, Y. Ke, and R. J. Solaro p21-Activated kinase-1 and its role in integrated regulation of cardiac contractility Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R963 - R973. [Abstract] [Full Text] [PDF]

				R. J. Sandoval, E. R. Injeti, J. M. Williams, W. T. Georthoffer, and W. J. Pearce Myogenic contractility is more dependent on myofilament calcium sensitization in term fetal than adult ovine cerebral arteries Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H548 - H556. [Abstract] [Full Text] [PDF]

				R. Stockton, J. Reutershan, D. Scott, J. Sanders, K. Ley, and M. A. Schwartz Induction of Vascular Permeability: betaPIX and GIT1 Scaffold the Activation of Extracellular Signal-regulated Kinase by PAK Mol. Biol. Cell, June 1, 2007; 18(6): 2346 - 2355. [Abstract] [Full Text] [PDF]

				T. Morita, T. Mayanagi, T. Yoshio, and K. Sobue Changes in the Balance between Caldesmon Regulated by p21-activated Kinases and the Arp2/3 Complex Govern Podosome Formation J. Biol. Chem., March 16, 2007; 282(11): 8454 - 8463. [Abstract] [Full Text] [PDF]

				M. E. Cuomo, A. Knebel, G. Platt, N. Morrice, P. Cohen, and S. Mittnacht Regulation of Microfilament Organization by Kaposi Sarcoma-associated Herpes Virus-cyclin{middle dot}CDK6 Phosphorylation of Caldesmon J. Biol. Chem., October 28, 2005; 280(43): 35844 - 35858. [Abstract] [Full Text] [PDF]

				B. A. Webb, R. Eves, S. W. Crawley, S. Zhou, G. P. Cote, and A. S. Mak PAK1 induces podosome formation in A7r5 vascular smooth muscle cells in a PAK-interacting exchange factor-dependent manner Am J Physiol Cell Physiol, October 1, 2005; 289(4): C898 - C907. [Abstract] [Full Text] [PDF]

				K.-E. Andersson and A. Arner Urinary Bladder Contraction and Relaxation: Physiology and Pathophysiology Physiol Rev, July 1, 2004; 84(3): 935 - 986. [Abstract] [Full Text] [PDF]

				Y. Wang, M. R. El-Zaru, H. K. Surks, and M. E. Mendelsohn Formin Homology Domain Protein (FHOD1) Is a Cyclic GMP-dependent Protein Kinase I-binding Protein and Substrate in Vascular Smooth Muscle Cells J. Biol. Chem., June 4, 2004; 279(23): 24420 - 24426. [Abstract] [Full Text] [PDF]

				T. Borbiev, A. D. Verin, A. Birukova, F. Liu, M. T. Crow, and J. G. N. Garcia Role of CaM kinase II and ERK activation in thrombin-induced endothelial cell barrier dysfunction Am J Physiol Lung Cell Mol Physiol, July 1, 2003; 285(1): L43 - L54. [Abstract] [Full Text] [PDF]

				P. K. McFawn, L. Shen, S. G. Vincent, A. Mak, J. E. Van Eyk, and J. T. Fisher Calcium-independent contraction and sensitization of airway smooth muscle by p21-activated protein kinase Am J Physiol Lung Cell Mol Physiol, May 1, 2003; 284(5): L863 - L870. [Abstract] [Full Text] [PDF]

				K. Sakurada, H. Kato, H. Nagumo, H. Hiraoka, K. Furuya, T. Ikuhara, Y. Yamakita, K. Fukunaga, E. Miyamoto, F. Matsumura, et al. Synapsin I Is Phosphorylated at Ser603 by p21-activated Kinases (PAKs) in Vitro and in PC12 Cells Stimulated with Bradykinin J. Biol. Chem., November 15, 2002; 277(47): 45473 - 45479. [Abstract] [Full Text] [PDF]

				S. M. Roth, R. E. Ferrell, D. G. Peters, E. J. Metter, B. F. Hurley, and M. A. Rogers Influence of age, sex, and strength training on human muscle gene expression determined by microarray Physiol Genomics, September 3, 2002; 10(3): 181 - 190. [Abstract] [Full Text] [PDF]

				K. G. Morgan and S. S. Gangopadhyay Signal Transduction in Smooth Muscle: Invited Review: Cross-bridge regulation by thin filament-associated proteins J Appl Physiol, August 1, 2001; 91(2): 953 - 962. [Abstract] [Full Text] [PDF]

				T. L. Cornwell, J. Li, H. Sellak, R. T. Miller, and R. A. Word Reorganization of Myofilament Proteins and Decreased cGMP-Dependent Protein Kinase in the Human Uterus during Pregnancy J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3981 - 3988. [Abstract] [Full Text] [PDF]

				M. A. Dechert, J. M. Holder, and W. T. Gerthoffer p21-activated kinase 1 participates in tracheal smooth muscle cell migration by signaling to p38 MAPK Am J Physiol Cell Physiol, July 1, 2001; 281(1): C123 - C132. [Abstract] [Full Text] [PDF]

				L. J. Janssen Isoprostanes: an overview and putative roles in pulmonary pathophysiology Am J Physiol Lung Cell Mol Physiol, June 1, 2001; 280(6): L1067 - L1082. [Abstract] [Full Text] [PDF]

				Z. M. Goeckeler, R. A. Masaracchia, Q. Zeng, T.-L. Chew, P. Gallagher, and R. B. Wysolmerski Phosphorylation of Myosin Light Chain Kinase by p21-activated Kinase PAK2 J. Biol. Chem., June 9, 2000; 275(24): 18366 - 18374. [Abstract] [Full Text] [PDF]

M. J. McManus, J. L. Boerner, A. J. Danielsen, Z. Wang, F. Matsumura, and N. J. Maihle An Oncogenic Epidermal Growth Factor Receptor Signals via a p21-activated Kinase-Caldesmon-Myosin Phosphotyrosine Complex J. Biol. Chem., November 3, 2000; 275(45): 35328 - 35334. [Abstract] [Full Text] [PDF]